13-Nov-2024 12:00 AM CST - Business Wire Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results #ANKET--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today announced its business update and financial results for the first nine months of 2024. "Im honored to join Innate Pharma at such a pivotal moment in its evolution, said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. We achieved notable regulatory milestones during the quarter including encouraging initial feedback from the FDA for lacutama
13-Nov-2024 12:00 AM CST - Business Wire Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results #ANKET--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today announced its business update and financial results for the first nine months of 2024. "Im honored to join Innate Pharma at such a pivotal moment in its evolution, said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. We achieved notable regulatory milestones during the quarter including encouraging initial feedback from the FDA for lacutama
